Atlas Trials

Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms

Clinical trial NCT03947411 · UNKNOWN

Trial details

NCT number
NCT03947411
Sponsor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Severe Influenza
Start date
2019-03-04
Primary completion
2020-03-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.